Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Kayyem Jon Faiz. Insider active across 4 companies, notably Inhibrx, Inc.. Cumulatively, 23 disclosures have been recorded. Split: 4 buys · 6 sells. Total volume traded: €3.1m. Activity tracked since 2 August 2022. The latest transaction was filed on 27 March 2025 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kayyem Jon Faiz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Kayyem Jon Faiz is Director at Inhibrx Biosciences, Inc., Inhibrx, Inc. and BIODESIX INC, and SVP, Research & Development at GenMark Diagnostics, Inc. The declarant has 23 filings in total, and based on the sampled recent filings, the buy and sell amounts are 2487909 and 89867685 EUR between 2016-01-25 and 2025-03-28.